Are low-intensity induction strategies better for older patients with acute myeloid leukemia? Academic Article uri icon


MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Induction Chemotherapy
  • Leukemia, Myeloid, Acute


  • This study compares outcomes of low-intensity versus standard-intensity induction strategies for older patients with acute myeloid leukemia at the Weill Cornell Leukemia Program. From 1999 to 2009, 298 adults ≥ 60 years with AML underwent induction chemotherapy with low-intensity and standard-intensity regimens, based on physician and patient preferences and investigational protocol availability. Overall, 33% of the cohort achieved complete remission with initial treatment, 23% with low-intensity induction and 53% with standard-intensity induction (P<0.0001). The median overall survival was 6.5 months and there was no significant difference in overall survival between patients initially treated with a low-intensity regimen compared to those receiving standard-intensity induction. There were no differences in 30- or 60-day mortality between the two groups.

publication date

  • April 2012



  • Academic Article



  • eng

PubMed Central ID

  • PMC3626084

Digital Object Identifier (DOI)

  • 10.1016/j.leukres.2011.12.019

PubMed ID

  • 22325245

Additional Document Info

start page

  • 407

end page

  • 12


  • 36


  • 4